Functional imaging of hippocampal dysfunction among persons with Alzheimer&rsquo;s disease: a proof-of-concept study

Código QR

Functional imaging of hippocampal dysfunction among persons with Alzheimer&rsquo;s disease: a proof-of-concept study

David B Arciniegas1,2, Jason R Tregellas1,3, Donald C Rojas1, Burlleen Hewitt1, C Alan Anderson1,2,41Neurobehavioral Disorders Program, Department of Psychiatry, 2Behavioral Neurology Section, University of Colorado Denver, Aurora, CO, USA; 3Research Service, 4Neurology Service, Denver Veterans Affa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	David B Arciniegas, Jason R Tregellas, Donald C Rojas, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8979ee0e19dd47ceaa8c07fa6de22861
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Diffusion tensor imaging investigations in Alzheimer&rsquo;s disease: the resurgence of white matter compromise in&nbsp;the cortical dysfunction of the aging brain
por: David A Medina, et al.
Publicado: (2008)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Neurosteroids block the increase in intracellular calcium level induced by Alzheimer&rsquo;s &beta;-amyloid protein in long-term cultured rat hippocampal neurons
por: Midori Kato-Negishi, et al.
Publicado: (2008)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
por: Weiming Xia
Publicado: (2010)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
por: Joseph Martin Alisky
Publicado: (2008)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
por: Mustafa M Husain, et al.
Publicado: (2008)

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
por: Zhou L, et al.
Publicado: (2016)

Optimal management of Alzheimer&rsquo;s disease patients: Clinical guidelines and family advice
por: Julia Haberstroh, et al.
Publicado: (2010)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

Could lysine supplementation prevent Alzheimer&rsquo;s dementia? A novel hypothesis
por: Robert N Rubey
Publicado: (2010)

Brain ischemia and ischemic blood&ndash;brain barrier as etiological factors in sporadic Alzheimer&rsquo;s disease
por: Ryszard Pluta, et al.
Publicado: (2008)

Reproductive life events and Alzheimer&rsquo;s disease in Italian women: a retrospective study
por: Bono G, et al.
Publicado: (2012)

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer&rsquo;s disease
por: William J McGeown, et al.
Publicado: (2008)

Sleep disorders in Parkinson&rsquo;s disease
por: Israt Jahan, et al.
Publicado: (2009)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

Estrogen receptor-mediated neuroprotection: The role of the Alzheimer&rsquo;s disease-related gene seladin-1
por: Alessandro Peri, et al.
Publicado: (2008)

Legal medical consideration of Alzheimer’s disease patients’ dysgraphia and cognitive dysfunction a 6 month follow up
por: Onofri E, et al.
Publicado: (2016)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

Current options for the treatment of Paget&rsquo;s disease of the bone
por: Daniela Merlotti, et al.
Publicado: (2009)

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer&rsquo;s disease: a voxel-based morphometry study
por: Nakaaki S, et al.
Publicado: (2012)

The efficacy of mirtazapine in agitated patients with Alzheimer&rsquo;s disease: A 12-week open-label pilot study
por: Sibel Cakir, et al.
Publicado: (2008)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
por: Fernando MV Dias, et al.
Publicado: (2011)

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study
por: Zhang Z, et al.
Publicado: (2012)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)

Editor&rsquo;s choice: the best of 2011&ndash;2012
por: Pinder RM
Publicado: (2013)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford J, et al.
Publicado: (2013)

Role of berberine in Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2016)

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
por: Osamu Kano, et al.
Publicado: (2009)

Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism
por: Alejandra Sekler, et al.
Publicado: (2008)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Effects of Co-Administration of Icariin and Panax notoginseng Saponins on Intestinal Microbiota and Hippocampal Protein Expression in a Mouse Model of Alzheimer’s Disease
por: Zhang T, et al.
Publicado: (2020)

Cerebral small vessel disease and Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2015)

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease: A Proof-of-Concept Six Years Prospective Study
por: Florinda Ferreri, et al.
Publicado: (2021)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)